0 Comments
0 Shares
451 Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
Gamma Delta T Cell Cancer Therapy Market – Next-Generation Immunotherapy Drives Oncology InnovationThe gamma delta T cell cancer therapy market is expanding as biotechnology companies, researchers, and oncology providers invest in novel cell-based approaches for cancer treatment. The market was valued at USD 500 million in 2024 and is projected to grow from USD 700 million in 2025 to USD 5 billion by 2035, at a reported CAGR of 22.3%. 1168 Gamma delta T cells are a distinct group of immune...0 Comments 0 Shares 91 Views 0 Reviews
-
Immunotherapy Market Report 2025–2035: AI, Precision Medicine, and Cell Therapy Drive Future GrowthMarket Overview According to MarketGenics, the global Immunotherapy Market is valued at USD 244.1 billion in 2025 and is projected to reach USD 564.3 billion by 2035, registering a CAGR of 8.7% during the forecast period. The market is experiencing robust growth due to the increasing adoption of immunotherapy as a preferred treatment option for cancer, autoimmune disorders, infectious...0 Comments 0 Shares 214 Views 0 Reviews
-
Immunotherapy Market Report 2025–2035: AI, Precision Medicine, and Cell Therapy Drive Future GrowthMarket Overview According to MarketGenics, the global Immunotherapy Market is valued at USD 244.1 billion in 2025 and is projected to reach USD 564.3 billion by 2035, registering a CAGR of 8.7% during the forecast period. The market is experiencing robust growth due to the increasing adoption of immunotherapy as a preferred treatment option for cancer, autoimmune disorders, infectious...0 Comments 0 Shares 280 Views 0 Reviews
-
Oncology and Immunotherapy Car T Cell Therapy Market Future OutlookImmunotherapy has fundamentally rewritten the rules of modern clinical medicine by training the body's natural defenses to eradicate disease. Consequently, the Car T Cell Therapy Market is entering a transformational growth phase as clinical research broadens beyond blood cancers into solid tumors and autoimmune disorders. While early market success was built on targets like CD19 for treating...0 Comments 0 Shares 501 Views 0 Reviews
-
GVHD Treatment Market to Reach USD 2.1 Billion by 2031 | CAGR 8.5%According to a newly published market research report by 24LifeSciences, global Graft Versus Host Disease (GVHD) Treatment market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.1 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.5% during the forecast period 20252031. Graft versus Host Disease, a serious complication following stem cell or bone...0 Comments 0 Shares 2K Views 0 Reviews
-
Pioneering Therapeutic Frontiers: Cancer Immunotherapy Market Growth, Opportunities, and Strategic Analysis by 2031The Cancer Immunotherapy Market is at the forefront of revolutionizing cancer care, offering transformative treatment options that harness the body’s immune system to combat malignancies more effectively. According to industry projections, the Cancer Immunotherapy Market size is expected to reach US$ 319,946 million by 2031, with the market anticipated to register a compound annual growth...0 Comments 0 Shares 2K Views 0 Reviews